Helen Hernandez,Ms, Pmp
About Helen Hernandez,Ms, Pmp
Helen Hernandez is a Senior Director of Program Management at KalVista Pharmaceuticals Limited, with extensive experience in drug development and project management across various therapeutic areas. She holds a B.S. in Life Science from the New York Institute of Technology and an M.S. in Biology from St. John's University.
Work at KalVista Pharmaceuticals
Helen Hernandez serves as the Senior Director of Program Management at KalVista Pharmaceuticals Limited. She has held this position since 2011, contributing to the company's strategic initiatives and program management efforts. Her role involves overseeing various phases of drug development and ensuring alignment with regulatory requirements. As a member of the Senior Management Team, she plays a key role in reviewing Good Laboratory Practice (GLP), Good Clinical Practice (GCP), and contracting Standard Operating Procedures (SOPs).
Education and Expertise
Helen Hernandez holds a Bachelor of Science degree in Life Science from the New York Institute of Technology. She furthered her education by obtaining a Master of Science degree in Biology from St. John's University. Additionally, she studied project management at the Project Management Institute, enhancing her skills in program management. Her educational background supports her extensive experience in managing drug development programs across various therapeutic areas.
Background
Before joining KalVista Pharmaceuticals, Helen Hernandez worked at Ora (Ophthalmic Research Associates) as an Executive Project Manager in the Retina Division for seven months in 2010. She also served as a Project Management Consultant at Ora for one month in the same year. Earlier in her career, she was a Biology Teacher at the NYC Department of Education from 1994 to 1997. Her diverse background in education and project management has shaped her approach to program management in the pharmaceutical industry.
Achievements
Helen Hernandez has extensive experience in managing programs and projects across various phases of drug development, including Nonclinical, Chemistry, Manufacturing, and Controls (CMC), Clinical Phase 1 through Phase 3, and Regulatory Investigational New Drug (IND) submission. She specializes in therapeutic areas such as diabetes, ophthalmology, hereditary angioedema (HAE), and cardiovascular diseases. Her strong skills in contract management and negotiation with Contract Research Organizations and consultants contribute to her effectiveness in program management.
Skills and Tools
Helen Hernandez possesses strong skills in using project management tools, including Microsoft Project and Smartsheet, for timeline and plan development. Her proficiency in these tools supports her ability to manage complex projects effectively. Additionally, her fluency in Spanish enhances her communication capabilities in diverse project environments, allowing her to collaborate effectively with various stakeholders.